Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-01-18-Speech-2-534-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110118.20.2-534-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"It is estimated that 9.9 million people in Europe suffer from a neurodegenerative disease, such as Alzheimer’s disease. With Europe’s population ageing, Eurostat estimates that twice as many people will be suffering from a neurodegenerative disease in 2050 as were in 1995. Moreover, since the burden of care falls on family members, it is estimated that the disease affects three members of a patient’s family. In this regard, it must be ensured that action is taken at EU level to help Member States to give appropriate assistance to patients and their families.
I totally agree that EU health policy should prioritise dementia. Proper recognition must be given to patient and carer organisations, and those same organisations must be involved in information campaigns and in the preparation of research programmes. The EU gives a considerable amount of money – EUR 159 million – to 34 neurodegenerative disease research programmes, but since there will be a huge increase in these diseases, research projects under the Eighth Framework Programme must be broadened to include research on behavioural, cognitive and non-drug therapies."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples